Cargando…

Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma

BACKGROUND: Xanthine dehydrogenase (XDH) is a critical enzyme involved in the oxidative metabolism of purines, pterin and aldehydes and a central component of the innate immune system. However, the prognostic value of XDH in predicting tumor-infiltrating lymphocyte abundance, the immune response, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhen, Xie, Yi-Zhao, Zhao, Ming-Chun, Hou, Pin-Pin, Tang, Juan, Chen, Guang-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425161/ https://www.ncbi.nlm.nih.gov/pubmed/34496841 http://dx.doi.org/10.1186/s12935-021-02173-7

Ejemplares similares

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma
por: Pang, Yilin, et al.
Publicado: (2021)

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma
por: Chen, G-L, et al.
Publicado: (2017)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Single nucleotide polymorphism at alcohol dehydrogenase-1B is associated with risk of esophageal squamous cell carcinoma
por: Ye, Bo, et al.
Publicado: (2014)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

The mechanism and significance of the conversion of xanthine dehydrogenase to xanthine oxidase in mammalian secretory gland cells
por: Kusano, Teruo, et al.
Publicado: (2022)

Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma
por: Liu, Xiangye, et al.
Publicado: (2020)

Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
por: Nakano, M., et al.
Publicado: (2021)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

Mutation of OsSAC3, Encoding the Xanthine Dehydrogenase, Caused Early Senescence in Rice
por: Xie, Ziyu, et al.
Publicado: (2022)

Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
por: Sun, Xiang-Hong, et al.
Publicado: (2020)

Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
por: Wang, Zhihui, et al.
Publicado: (2021)

Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
por: Li, Tian-Fu, et al.
Publicado: (2020)

Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues.
por: Anderson, R. F., et al.
Publicado: (1989)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
por: Wu, Wenlong, et al.
Publicado: (2021)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
por: Tang, Li-juan, et al.
Publicado: (2019)

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
por: Wu, Hua-Hui, et al.
Publicado: (2021)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
por: Li, Ping, et al.
Publicado: (2019)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Wang, Yi, et al.
Publicado: (2021)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
por: Xu, Yu-Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6g76678vmq0ghmv8c513b8dvhn